๐
Mavenclad
cladribine
Multiple Sclerosis
โ
Authorised
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Treatment of adult patients with highly active relapsing multiple sclerosis (MS) as defined by clinical or imaging features.
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/mavenclad